U.S. authorizes Moderna, Pfizer-BioNTech vaccine as boosters
CGTN
Share
Copied
The U.S. Food and Drug Administration on Wednesday authorized the retooled COVID-19 booster shots of both Moderna and Pfizer-BioNTech that target the currently dominant BA.4/BA.5 Omicron variants of the coronavirus.